System Transmission

Top Signal

100#1 JOB

Activity

2192Ripe

+952 today

System

Livenow

Terminal Asset View

stockNASDAQ

BHVN

$9.58-3.33%

Biohaven Ltd

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

11Overripe

Live Analysis Active

Company Mission

Biohaven Ltd creates prescription drugs that treat neurological conditions such as migraines, depression, and other brain-related disorders. Doctors prescribe these medications to patients who need relief from these conditions. The company makes money by selling these drugs to pharmacies and healthcare providers, and through partnerships where other companies pay to use their research or technology.

BHV

Industry Context

The biotechnology industry focuses on developing new medical treatments using biological processes. Companies in this sector invest heavily in research and development, with their stock prices often reacting strongly to news about drug trials, regulatory approvals, or scientific breakthroughs.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

53Matrix

Market Momentum

35.3— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.8x— Normal Volume

Today's Change

-3.33%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing BHVN across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 04:28 PM UTC

As-of 03-14-2026 16:12 UTC

Develops drugs for neurological diseases and makes money by selling these treatments through pharmacies and hospitals.

Price remains below key moving averages, suggesting the stock is in a downtrend that needs to be monitored for potential stabilization showing showing consolidation pattern.

Biotech sector faces volatility as regulatory approvals and clinical trial results drive investor sentiment, creating opportunities for companies, suggesting for companies.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...